dvantagene   

Estuardo Aguilar-Cordova, MD inf., PhD

CEO, Chairman (Harvard Gene Therapy Initiative, Baylor College of Medicine, Cetus, FDA BRMAC and VRPAC Advisory Committees, Recombinant DNA Advisory Committee, NIH)

Laura K. Aguilar, MD, PhD

VP, Clinical Research (Harvard Gene Therapy Initiative, Baylor College of Medicine, Board Certified Hem/Onc.)

Brian Guzik, PhD, MBA

Director, Business Development (Cornell Capital Partners, HHMI/UCSD, Univ. of Virginia)

Jill Brace O’Neill, MS, PNP
Director, Clinical Research (Dana Farber Cancer Institute, Texas Children’s Cancer Center, Rhode Island Hospital/Hasbro Children’s Hospital)
 

Key Team Members